West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 346,200 | 247,800 | 165,500 | 74,300 | 241,700 |
| Depreciation Amortization | 109,100 | 80,600 | 52,200 | 26,000 | 103,400 |
| Income taxes - deferred | -5,800 | N/A | N/A | N/A | 15,300 |
| Accounts receivable | -46,600 | N/A | N/A | N/A | -33,300 |
| Accounts payable and accrued liabilities | 36,600 | N/A | N/A | N/A | 25,300 |
| Other Working Capital | -10,300 | -34,900 | -27,300 | -45,600 | -14,400 |
| Other Operating Activity | 43,300 | 30,300 | 14,800 | 2,400 | 29,200 |
| Operating Cash Flow | $472,500 | $323,800 | $205,200 | $57,100 | $367,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -174,400 | -116,700 | -69,200 | -32,100 | -126,400 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -18,900 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -85,100 |
| Purchase Sale Intangibles | N/A | -3,800 | -3,800 | N/A | N/A |
| Other Investing Activity | -5,100 | -5,200 | -3,600 | 200 | 2,400 |
| Investing Cash Flow | $-179,500 | $-121,900 | $-72,800 | $-31,900 | $-228,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 198,500 |
| Debt Repayment | -2,300 | -1,700 | -1,100 | -600 | -136,400 |
| Common Stock Issued | 34,700 | 26,600 | 21,300 | 8,800 | 32,700 |
| Common Stock Repurchased | -121,400 | -117,800 | -117,800 | -116,700 | -85,300 |
| Dividend Paid | -48,100 | -35,500 | -23,600 | -11,800 | -45,100 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1,200 |
| Financing Cash Flow | $-137,100 | $-128,400 | $-121,200 | $-120,300 | $-36,800 |
| Exchange Rate Effect | 20,500 | 6,800 | -4,400 | -8,700 | -700 |
| Beginning Cash Position | 439,100 | 439,100 | 439,100 | 439,100 | 337,400 |
| End Cash Position | 615,500 | 519,400 | 445,900 | 335,300 | 439,100 |
| Net Cash Flow | $176,400 | $80,300 | $6,800 | $-103,800 | $101,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 472,500 | 323,800 | 205,200 | 57,100 | 367,200 |
| Capital Expenditure | -174,400 | -116,700 | -69,200 | -32,100 | -126,400 |
| Free Cash Flow | 298,100 | 207,100 | 136,000 | 25,000 | 240,800 |